As CML Outcomes Improve, Demand Rises for BCR::ABL1 Testing
Patients with chronic myeloid leukemia need regular BCR::ABL1 testing for the rest of their lives, which can translate into more lab work.
Read MorePosted by Chris Wolski | Mar 20, 2023 | Leukemia, Molecular Diagnostic Analyzers |
Patients with chronic myeloid leukemia need regular BCR::ABL1 testing for the rest of their lives, which can translate into more lab work.
Read MorePosted by Andy Lundin | Mar 2, 2023 | Cancer |
Investigators at Children’s Hospital Los Angeles investigators have developed a liquid biopsy for pediatric solid tumors.
Read MorePosted by Andy Lundin | Feb 16, 2023 | Cancer |
Eurofins launched a test that can assess the expansion and persistence of CAR-T therapy in patients with certain leukemia and lymphomas.
Read MorePosted by Andy Lundin | Feb 6, 2023 | Leukemia |
Identifying recurrent genetic alterations in myeloid neoplasms has improved diagnosis and expanded targeted treatments available to patients.
Read MorePosted by Andy Lundin | Jan 25, 2023 | Company News, Leukemia |
Alercell has launched a new website—Lena Diagnostics—dedicated to proprietary tests focused on early detection of cancer and leukemia.
Read More